Dr. Gwendolyn Rene Akers, D.O. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 763 Johnsonburg Rd, Saint Marys, PA 15857 Phone: 814-788-8186 Fax: 814-788-8033 |
Dr. Anujit Singh, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 761 Johnsonburg Rd, Suite 220, Saint Marys, PA 15857 Phone: 814-788-8184 Fax: 814-788-8078 |
News Archive
Living with a partner and having good health are key sources of happiness for both young men and women, according to a new report from researchers in the Department of Sociology at Bristol University.
Researchers in the Department of Orthopaedics at Stony Brook University Medical Center have developed an injectable form of the enzyme, collagenase, that significantly improves outcomes of Dupuytren's contracture (or disease), a debilitating disorder caused by progressive accumulation of collagen that deforms fingers and limits motion. Reported in September 3, 2009, issue of The New England Journal of Medicine, the study involved treatment of 308 patients with Duputren's disease in 16 sites nationwide. The results indicate that the injections are safe and effective.
Dr. Elisabetta Patorno, a research fellow at Brigham and Women's Hospital and Harvard Medical School in Boston has published a study this week in the Journal of American Medical Association which found that taking anticonvulsant drugs raise thoughts of suicide and risks of actually trying to commit suicide by two times the norm. The study was sponsored by the Harvard School of Public Health and HealthCore, a research subsidiary of WellPoint. WellPoint is a health benefits company that serves the Blue Cross Blue Shield network.
Treatment with the anti-hypertensive drug valsartan (Diovan) led to a modest reduction in the development of type 2 diabetes but did not significantly reduce cardiovascular events in patients with impaired glucose tolerance, according to researchers at Duke University Medical Center and the University of Oxford. They jointly reported results at the American College of Cardiology meeting today from the world's first study designed to find ways to control the progression to diabetes and cardiovascular disease in people at risk.
› Verified 7 days ago